Enhancing Cancer Patients' Prospects
Two types of cancer's genetic abnormalities have been discovered by researchers.
The two most deadly types of cancer, glioblastoma and pancreatic cancer, have a number of genetic flaws that contribute to them. According to researchers, their discoveries will lead to the creation of revolutionary diagnostic techniques that would enable earlier detection of tumors that are currently incurable.
Malignant gliomas make up the great majority of glioblastomas and pancreatic tumors, which have poor prognoses with a five-year survival rate of barely 5%.
Dr. Paula B. Gibbons is a senior editor at Science magazine and a cancer researcher. The finding of multiple genetic flaws that lead to these tumors was described in two publications that were published in the journal last week.
According to Dr. Gibbons, these discoveries might help in providing the answers to two important queries. Patients frequently ask their doctor two questions after receiving a cancer diagnosis: Can you cure my cancer? What's the outlook for my cancer?
According to Dr. Gibbons, the most current research could ultimately help cancer patients.
Researchers from the Howard Hughes Medical Institute in Maryland and the Ludwick Center at John Hopkins University led two teams that meticulously examined 20,000 genes within 46 patients with pancreatic cancer and glioblastoma as part of a comprehensive study designed to find the underlying causes of gliomas and pancreatic cancer.
There are around 12 mechanisms, all of which are regulated by defective genes, that are responsible for each type of cancer, according to research. According to research on pancreatic cancer, 67% to 100% of instances are thought to be caused by mutations in these genes.
The discovery of a novel mutation in the IDH1 gene, which had not previously been linked to brain cancer, shocked the researchers.
The researchers said that glioblastoma is a condition that may require two separate treatment modalities because persons with defective genes frequently live longer.
Although both malignancies share certain characteristics, the researchers discovered that each cancer patient's gene combination is unique, making it unlikely that effective treatments for pancreatic and brain cancer will materialize anytime soon.
One of the researchers on the brain cancer project, Viktor Velculescu, a professor of medicine at John Hopkins University, said, "Now, at least I think we know who the enemy is, but it will still take a long time to take advantage of this discovery. But this study's findings have at least moved us forward a little.
For early diagnosis and detection
The Howard Hughes Medical Institute's top researcher, Bert Vogelstein, is an essential component of the cancer investigation. He claims that the research will make it feasible to pinpoint specific gene markers that contribute to the development of pancreatic and glioblastoma tumors.
According to experts, these two malignancies are accompanied by 70 highly active genes, making them suitable targets for early detection and investigation.
According to Vogelstein, the history of medicine shows that disease can be best controlled by prevention rather than treatment. Despite the fact that polio is still incurable, it is hardly ever observed. We have a special opportunity when it comes to cancer since you don't actually have to prevent it. All you have to do is find it before the cancer cells begin to spread. In this way, simple surgery can effectively treat almost all patients.
The complexity of the gene charts linked to breast cancer and colon cancer are similar, according to research conducted by Vogelstein and his colleagues last year.
This discovery hinders efforts to target particular genes with drugs, an objective of research. In other words, the goal is to identify as many mutations in the genes that cause cancer as possible, and then to treat each mutant gene with a medicine.
